placebo 78%±29%), although this difference did not reach statistical significance, likely due to inadequate power.
← all excerpts
Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial.
1
—
—
placebo 78%±29%), although this difference did not reach statistical significance, likely due to inadequate power.